US Patent 10278923 Oral dosing of GLP-1 compounds
Patent 10278923 was granted and assigned to Novo Nordisk on May, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10278923 Oral dosing of GLP-1 compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
